Article info

Download PDFPDF
General medicine
Should patients with atrial fibrillation and stable coronary artery disease receive an oral anticoagulant, an antiplatelet or both?

Authors

  1. Correspondence to Dr Mark T Mills, Department of Cardiology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield S5 7AU, UK; marktmills1{at}gmail.com
View Full Text

Citation

Mills MT
Should patients with atrial fibrillation and stable coronary artery disease receive an oral anticoagulant, an antiplatelet or both?

Publication history

  • Accepted May 6, 2020
  • First published June 3, 2020.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.